Trials / Sponsors / BeyondSpring Pharmaceuticals Inc.
BeyondSpring Pharmaceuticals Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance | Phase 3 | 2026-06-01 |
| Unknown | Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia Chemotherapy-induced Neutropenia | Phase 3 | 2019-10-23 |
| Completed | Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy P Chemotherapy-induced Neutropenia | Phase 3 | 2018-05-29 |
| Completed | Plinabulin iv Solution in Prevention of TAC Induced Neutropenia Chemotherapy-induced Neutropenia | Phase 2 | 2017-11-27 |
| Completed | Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy P Chemotherapy-induced Neutropenia | Phase 2 | 2017-04-05 |
| Completed | Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC Non-Small Cell Lung Cancer | Phase 3 | 2015-12-01 |